Transcript
Stabilis Noms commerciaux Aximad Batixim Betaksim Biotaksym Cefomit Ceftax Centiax Claforan Deforan Doksetil Letynol Lirgosin Makrocef Molelant Naspor Phacocef Ralopar Rantaksyn Refotax Reftax Salocef Sefagen Sefoksim Sefotak Spectrocef Spirosine Stoparen Tarcefoksym Taxcef Taxime Taxocef Tirotax Totam Valoran Xame Zariviz Tchéquie Afrique du sud, Autriche, Belgique, Brésil, Canada, Danemark, Egypte, Espagne, Finlande, France,, Hongrie,, Pays bas, Russie, Suède, Suisse, Thaïlande, Slovénie Portugal Afrique du sud Tchéquie, Tchéquie Afrique du sud Thaïlande - 23/01/ :29 - Page 1 Stabilité des solutions 20 mg/ml 24 C mg/ml 2-8 C mg/ml 25 C mg/ml -10 C mg/ml 24 C mg/ml 4 C mg/ml 24 C mg/ml -20 C mg/ml 25 C mg/ml 4 C ,86 mg/ml 37 C ,92 mg/ml 25 C ,80 mg/ml 37 C ,87 mg/ml 25 C mg/ml 2-8 C mg/ml 25 C mg/ml 25 C mg/ml 5 C & 40 mg/ml 25 C Stabilité en mélange 20 mg/ml 24 C 20 mg/ml 24 C 10 mg/ml 28 C 10 mg/ml 5 C 5 mg/ml 20 C Clindamycin phosphate : 9 mg/ml Clindamycin phosphate : 9 mg/ml Metronidazole : 5 mg/ml Metronidazole : 5 mg/ml Tinidazole : 2 mg/ml /01/ :29 - Page 2 Facteur influençant la stabilité 4,5 ph 5,5 592 Incompatibilités Allopurinol sodium : 3 mg/ml Amikacin sulfate Amphotericin B : 200 mg/ml Azithromycine : 2 mg/ml Cisatracurium besylate : 2 & 5 mg/ml Filgrastim : 30 µg/ml Fluconazole : 2 mg/ml Gemcitabine hydrochloride : 38 mg/ml Gentamicin sulfate : 10 mg/ml Heparin sodium : 5000 UI/ml Hetastarch : 20 mg/ml Omeprazole sodium Pantoprazole sodium Pemetrexed disodium : 20 mg/ml Pentamidine isetionate : 3 mg/ml : 100 mg/ml Salbutamol sulfate : 1 mg/ml : 100 mg/ml Thiopental sodium : 25 mg/ml : 100 mg/ml Vancomycin hydrochloride : 25 & 30 mg/ml : 50 200 mg/ml Vancomycin hydrochloride : 20 mg/ml /01/ :29 - Page 3 Voie d administration Bibliographie Type Source 244 Revue Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: Revue Szof C, Walker PC. Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration. Am J Hosp Pharm 1993 ; 50: 2054, Revue Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: Revue Belliveau PP, Nightingale CH, Quintiliani R. Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags. Am J Health-Syst Pharm 1995 ; 52: Revue Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: Revue Trissel LA, Martinez JF. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: Revue Foley PT, Bosso JA, Bair JN, Townsend RJ. Compatibility of clindamycin phosphate with cefotaxim sodium or netilmicin sulfate in small-volume admixtures. Am J Hosp Pharm 1985 ; 42: Revue Wohlford JG, Fowler MD. Visual compatibility of hetastarch with injectable critical-care drugs. Am J Hosp Pharm 1989 ; 46: Revue Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: Revue Barthes D, Fauconneau B, Martin JP, Courtois P. Effects of storage temperature and ph on the stability of cefotaxime in PVC bags. J Pharm Clin 1989 ; 8: Revue Das Gupta V. Stability of cefotaxime sodium as determined by High-Performance Liquid Chromatography. J Pharm Sci 1984 ; 73: Laboratoire Baxter Stabilité des médicaments dans l'intermate SV50, 100, Revue Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: /01/ :29 - Page 4 1452 Revue Muller HJ, Howe K, Frank C, Haker I. Stability of cefazolin, cefotiam, cefuroxime, cefotaxime, ceftriaxone and ceftazidime in normal saline solutions, stored in a new IV container made of Biofine*. Eur Hosp Pharm 2000 ; 6: Revue Trissel LA, Gilbert DL, Martinez JF. Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration. Hosp Pharm 1998 ; 33: Revue Das Gupta V. Stability of cefotaxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Int J Pharm Compound 2002 ; 6: Revue Voytilla KL, Tyler LS, Rusho WJ. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery. Am J Health-Syst Pharm 2002 ; 59: Revue Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: Revue Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: Revue Guo P, Li X, Wan J, You A. Study on the compatibility of cefotaxime with tinidazole in glucose injection. J Pharm Biomed Anal 2007 ; 43: Revue CM Paap CM, Nahata MC. Stability of cefotaxime in two peritoneal dialysis solutions Am J Hosp Pharm 1990 ; 47: Revue Baker D S, Waldrop Bruce, Arnold John. Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin. Int J Pharm Compound 2010 ; 14, 4: Revue Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G. Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y. Pharmactuel 2011 ; 44, 1 : Laboratoire Cidomycin solution for injection - Summary of product Chracteristics. Sanofi Laboratoire Amikacine B Braun - Résumé des caractéristiques du produit. B Braun Revue Legris M.E, Lavoie A, Forrest J.M, Hildgen P. Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 2014 ; 47, 3 : Poster Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M. Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables? Synprefh Congress Clermont Ferrand, France /01/ :29 - Page 5 Dictionnaire Antibiotique Injectable Noms commerciaux Stabilité des solutions Contenant Molécule Concentration Température Conservation Heure Biosimilaire Données conflictuelles Bibliographie Verre NaCl 0,9% ou glucose 5% Lumière Heure Chlorure de sodium 0,9% A l abri de la lumière Non précisée Polyvinyl chlorure Jour Glucose 5% Dianéal PD1 1.5% glucose (Baxter) Dianéal PD1 4.25% glucose (Baxter) Polypropylène Elastomère Stabilité en mélange Solvant Molécule Non précisé Facteur influençant la stabilité Provoque Augmentation stabilité Incompatibilités Chlorure de sodium 0,45% Voie d administration Intraveineuse Perfusion intraveineuse Intramusculaire Bibliographie Dictionnaire - 23/01/ :29 - Page 6
